title: [Treatment of advanced pancreatic cancer with interferon alpha, tumor necrosis factor and 5-fluorouracil (preliminary report].
abstract: This paper presents the first outcomes of a combined therapy of advanced cancer of pancreas with Interferon alpha, Tumor Necrosis and 5-Fluorouracil. Every subject underwent surgical treatment, but only in two cases partial resection was done. In the other subject only palliative operations were performed because of advances stages of neoplastic process. All patients were followed up during the time ranged between from 2.5-13.5 months. Complete remission was observed in one patient (survival time--9 months). In three subjects partial remission was reported, whereas in the left part of our cohort the general condition was steady. This research would be continued.
authors.affiliation: V Katedry i Kliniki Chorób Wewnetrznych Sl. Ak. Med. w Bytomiu.
authors.forename: M
authors.initials: M
authors.lastname: Muc
authors.forename: M
authors.initials: M
authors.lastname: Baranowski
authors.forename: R
authors.initials: R
authors.lastname: Braczkowski
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000601:surgery; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D012074:Remission Induction; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage
chemical_list: D016898:Interferon-alpha; D014409:Tumor Necrosis Factor-alpha; D005472:Fluorouracil
vernacular_title: Leczenie zaawansowanych postaci nowotworów trzustki za pomoca interferonu alfa, czynnika nekrozy nowotworów i 5-fluorouracylu (doniesienie wstepne).